公司資料
LeMaitre Vascular 股價、新聞與催化劑
- 股票代碼:
- LMAT
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
80.19 USD (-2.91%)
收盤價
最後更新: 2026年10月1日
2.09B USD
市值
股價為何變動
截至 2026年10月1日，LMAT 下跌 2.91%，收於 $80.19。目前新聞監測窗口內未發現新的同公司新聞。
公司概覽
Vascular Device Company
LeMaitre Vascular develops devices, implants, and services used by vascular surgeons to treat peripheral vascular disease. Its portfolio is focused on open surgical and endovascular procedures outside the heart.
Grafts and Biological Implants
The company offers synthetic vascular grafts, Artegraft biological grafts, vascular patches, and related implants used to repair or replace diseased vessels. These products generate procedure-linked demand and are supported by specialized surgeon relationships.
Catheters and Surgical Tools
LeMaitre supplies embolectomy catheters, occlusion catheters, carotid shunts, valvulotomes, and other devices used during vascular reconstruction. The portfolio addresses multiple steps within common vascular procedures.
Direct Commercial Model
The company primarily sells through a direct sales force in major markets, supported by distributors elsewhere. Acquisitions and internal product development are used to expand the portfolio offered to the same vascular-surgery customer base.
未來催化劑
近期新聞
新聞標題由機器翻譯，詳情為英文原文。
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。